Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;13(12):1128-1131.
doi: 10.1136/neurintsurg-2020-016961. Epub 2021 Feb 1.

Duration of symptomatic stroke and successful reperfusion with endovascular thrombectomy for anterior circulation large vessel occlusive stroke

Affiliations

Duration of symptomatic stroke and successful reperfusion with endovascular thrombectomy for anterior circulation large vessel occlusive stroke

Adam de Havenon et al. J Neurointerv Surg. 2021 Dec.

Abstract

Background: It has been reported that longer time intervals from stroke onset to endovascular therapy are associated with lower rates of successful reperfusion in acute ischemic stroke patients with large vessel occlusion. However, procedural variables and potential mechanisms of this association have not been fully elucidated.

Methods: We performed a secondary analysis of individual patient data from the North American Solitaire Stent Retriever Acute Stroke (NASA) and Trevo Stent-Retriever Acute Stroke (TRACK) registries. We included patients with occlusion of the internal carotid artery or middle cerebral artery (M1 and M2 segments) who were treated by mechanical thrombectomy within 24 hours of last known normal. The primary outcome was reperfusion, defined as a Thrombolysis In Cerebral Infarction (TICI) score ≥2b. The secondary outcome was reperfusion on the first pass. The primary predictor was duration of symptomatic stroke, defined as time from last known normal to time of final pass. Adjusted logistic regression models were utilized to determine associations between variables and outcome.

Results: We included 506 patients, of which 401 (79.3%) achieved successful reperfusion (TICI 2b/3). The mean (SD) duration of symptomatic stroke was 6.8 (3.5) hours and in the adjusted logistic regression model the duration of symptomatic stroke was associated with reperfusion (OR 0.90, 95% CI 0.84 to 0.96) and reperfusion on the first pass (OR 0.89, 95% CI 0.83 to 0.95). In that model, the predicted probability of reperfusion was 88% (95% CI 0.83 to 0.92) at 1 hour, 81% (95% CI 0.78 to 0.84) at 6 hours, 70% (95% CI 0.63 to 0.77) at 12 hours, and 42% (95% CI 0.17 to 0.67) at 24 hours (ptrend=0.001). Reperfused patients were significantly younger, more likely to be male, and to have had a balloon guide catheter used during the procedure.

Conclusion: In a real-world cohort of acute ischemic stroke patients with anterior circulation occlusion treated with endovascular therapy, longer duration of symptomatic stroke is associated with lower rates of successful reperfusion and reperfusion on the first pass.

Keywords: acute ischemic stroke; endovascular thrombectomy; large vessel occlusion; neurologic outcome.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AD reports investigator initiated funding from AMAG and Regeneron pharmaceuticals. RGN reports consulting fees for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Imperative Care, Medtronic, Phenox, Prolong Pharmaceuticals, Stryker Neurovascular and stock options for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, and Perfuze. TN is Principal Investigator of the CLEAR study funded by Medtronic; serves on the Data Safety Monitoring Board for TESLA (Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke), ENDOLOW (Endovascular Therapy for Low NIHSS Ischemic Strokes), and SELECT 2 (A Randomized Controlled Trial to Optimize Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke) trials.

Figures

Figure 1.
Figure 1.
A) Histogram of clot dwell times, B) Predicted probability* of reperfusion for the middle cerebral artery (MCA) segments and internal carotid artery (ICA). *Adjusted for patient age, sex, race, baseline systolic blood pressure, NIH stroke scale, device (Solitaire vs. Trevo), site of occlusion, number of passes, balloon guide catheter, clot aspiration, rescue treatment, intravenous alteplase, and intraarterial alteplase.
Figure 2.
Figure 2.
Predicted probability* of A) reperfusion and B) first pass effect with 95% confidence interval. *Adjusted for patient age, sex, race, baseline systolic blood pressure, NIH stroke scale, device (Solitaire vs. Trevo), site of occlusion, number of passes (model fit to reperfusion only), balloon guide catheter, clot aspiration, rescue treatment, intravenous alteplase, and intraarterial alteplase.

Similar articles

Cited by

References

    1. Boyle K, Joundi R, Aviv R. An historical and contemporary review of endovascular therapy for acute ischemic stroke. Neurovascular Imaging 2017;3:1–12.
    1. Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20. doi:10.1056/NEJMoa1411587 - DOI - PubMed
    1. Campbell BCV, Mitchell PJ, Kleinig TJ, et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection 10.1056/NEJMoa1414792. 2015. doi:10.1056/NEJMoa1414792 - DOI - PubMed
    1. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30. doi:10.1056/NEJMoa1414905 - DOI - PubMed
    1. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke 10.1056/NEJMoa1503780. 2015. doi:10.1056/NEJMoa1503780 - DOI - PubMed